SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

thanks appreciate the response, I am long here,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BISerNOMORE Member Profile
 
Followed By 63
Posts 5,348
Boards Moderated 0
Alias Born 03/17/10
160x600 placeholder
Mast Therapeutics Provides Business Update "PR Newswire (US)" - 9/26/2016 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/26/2016 8:56:33 AM
Friendable Inc. (OTC Pink: FDBL), Increases Speed and Performance in App – Focused on User Experience "InvestorsHub NewsWire" - 9/22/2016 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/20/2016 5:20:03 PM
Mast Therapeutics Reports Top-Line Results From Phase 3 Study In Sickle Cell Disease "PR Newswire (US)" - 9/20/2016 5:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/12/2016 8:27:21 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/7/2016 7:48:00 AM
Mast Therapeutics Joins New Sickle Cell Disease Coalition, Supports Campaign To Improve Treatment And Care "PR Newswire (US)" - 9/6/2016 8:00:00 AM
Mast Therapeutics To Present At 18th Annual Rodman & Renshaw Global Investment Conference On September 13th "PR Newswire (US)" - 9/1/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/10/2016 9:02:44 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/9/2016 4:10:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2016 9:01:26 AM
Mast Therapeutics Reports Second Quarter 2016 Financial Results "PR Newswire (US)" - 8/9/2016 8:00:00 AM
Mast Therapeutics Awarded Small Business Innovation Research Grant From The National Institutes Of Health "PR Newswire (US)" - 8/8/2016 8:00:00 AM
Mast Therapeutics Announces Issuance Of Composition Of Matter Patent Covering Vepoloxamer "PR Newswire (US)" - 8/3/2016 8:00:00 AM
Mast Therapeutics To Present At 36th Annual Canaccord Genuity Growth Conference On August 10 "PR Newswire (US)" - 8/2/2016 8:00:00 AM
Mast Therapeutics Announces Initiation Of Phase 2 Study Of AIR001 Conducted By The Heart Failure Clinical Research Network "PR Newswire (US)" - 8/1/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/25/2016 5:03:24 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:23:39 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:21:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:21:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:17:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2016 4:18:04 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/8/2016 4:16:48 PM
Mast Therapeutics Receives Notice Of Allowance Of Composition Of Matter Patent Application Covering Vepoloxamer "PR Newswire (US)" - 6/8/2016 4:05:00 PM
BISerNOMORE   Friday, 03/23/12 10:19:53 AM
Re: Tommy post# 9637
Post # of 14537 
thanks appreciate the response, I am long here, just curious on fluctuations

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist